510(k) Report

510(k) · Cleared

Cleared

Dermablate Effect

K081541510(k) TraditionalCleared Feb 23, 2009266-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asclepion Laser Technologies GmbH · GEX Powered Laser Surgical Instrument

Cleared on Feb 23, 2009 after a 266-day review. The FDA summary names its predicate without a number. 85 later devices descend from it.

Decided
Feb 23, 2009
Review
266 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
0

85 later devices descend from it, 6 citing it directly.

Descendants, by year cleared 2015: 3 descendants cleared2014: 2 descendants cleared2018: 6 descendants cleared2012: 1 descendant cleared2022: 13 descendants cleared2017: 4 descendants cleared2016: 3 descendants cleared2026: 9 descendants cleared2021: 6 descendants cleared2023: 9 descendants cleared2025: 12 descendants cleared2024: 10 descendants cleared2019: 2 descendants cleared2020: 5 descendants cleared20052010201520202025
  1. This deviceK081541 Dermablate EffectAsclepion Laser Technologies GmbH · 2009
  2. Descendant · cites it directly · 70 of its ownK132806 Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014
  3. Descendant · 2 generations on · 62 of its ownK143723 SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP SpectroFotona D.D. · 2015
  4. Descendant · 3 generations on · 32 of its ownK153671 Family of CoolGlide Aesthetic LasersCutera, Inc. · 2016
  5. Descendant · 4 generations on · 24 of its ownK170626 Modified Alma Lasers Soprano XL Family of Multi-Application &…Alma Lasers, Inc. · 2017
  6. Descendant · 5 generations on · 22 of its ownK172193 Modified Alma Lasers Soprano XL™ Family ofMulti-Application &…Alma Lasers, Inc. · 2018

Showing 5 of 85 descendants. See all descendants

Descendants cleared per year

2012: 12014: 22015: 32016: 32017: 42018: 62019: 22020: 52021: 62022: 132023: 92024: 102025: 122026: 9
2012high 13 (2022) · low 0 (2013)2026

Most influential descendants

Showing 5 of 85 · See all
  • K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D. · 2014 · cites it directly70descendants
  • K143723SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP SpectroFotona D.D. · 2015 · 2 generations on62descendants
  • K153671Family of CoolGlide Aesthetic LasersCutera, Inc. · 2016 · 3 generations on32descendants
  • K170626Modified Alma Lasers Soprano XL Family of Multi-Application & Multi-Technology Platform…Alma Lasers, Inc. · 2017 · 4 generations on24descendants
  • K172193Modified Alma Lasers Soprano XL™ Family ofMulti-Application & Multi-Technology Platforms…Alma Lasers, Inc. · 2018 · 5 generations on22descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K081541Dermablate EffectAsclepion Laser Technologies GmbH2009—
+1K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D.2014—
+2K143723SP Dynamis, SP Spectro, XS Dynamis, XP Dynamis, XP SpectroFotona D.D.2015—
+3K153671Family of CoolGlide Aesthetic LasersCutera, Inc.2016—
+4K170626Modified Alma Lasers Soprano XL Family of Multi-Application & Multi-Technology…Alma Lasers, Inc.2017—
+5K172193Modified Alma Lasers Soprano XL™ Family ofMulti-Application & Multi-Technology…Alma Lasers, Inc.2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201420
201530
201630
201740
201860
201920
202050
202160
2022130
202390
2024100
2025120
202690
FIG. 1 — Lineage of K081541, 2009–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—MCL 30 Dermablate
Named without a submission number
—
*—Lux2940 Erbium Fractional Handpiece
Named without a submission number
—
*—Profile ProFractional Handpiece
Named without a submission number
—
*—Photosilk Plus
Named without a submission number
—
*—Cellactor SC1
Named without a submission number
—
*—D-Actor 200
Named without a submission number
—

What descends from it? (85)

See all 85

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K132806Fotona F-22 Laser Handpiece (F-Runner), Fotona FS-01 Laser HandpieceFotona D.D.201470
K112669Tattoostar Effect YAsclepion Laser Technologies GmbH20128
K150140MCL 31 DermablateAsclepion Laser Technologies GmbH20157
K173692D-Actor 200 Vibration Massage SystemStorz Medical AG20186
K152153MicroSpot HandpieceAsclepion Laser Technologies GmbH20156
K182682OrthoGold 100Tissue Regeneration Technologies20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K132806 (Fotona D.D., 2014) has gone furthest, with 70 descendants of its own.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Dermablate Effect Er:YAG laser with handpiece of larger spot sizes is intended for use for coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes). The Dermablate Effect Er:YAG laser with fractional handpiece is intended for dermatological and skin resurfacing procedures. The Dermablate Effect can be equipped optionally with the following modules…

Read the full statement (102 words)

The Dermablate Effect Er:YAG laser with handpiece of larger spot sizes is intended for use for coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes).

The Dermablate Effect Er:YAG laser with fractional handpiece is intended for dermatological and skin resurfacing procedures.

The Dermablate Effect can be equipped optionally with the following modules: Asclepion Pulsed Light (APL) and Acoustic Wave (AW).

The Asclepion Pulsed Light is intended for permanent hair reduction, treatment of vascular and pigmented lesions and inflammatory acne.

The Acoustic Wave is intended for the acti~,ation of connective tissue.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081541: Dermablate Effect.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K081541

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026